(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China for the treatment of patients with unresectable, locally advanced, or metastatic ...
(IN BRIEF) AstraZeneca and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) has received conditional approval in China for the treatment of patients with unresectable, locally advanced, or metastatic ...
Henkel Adhesive Technologies has achieved ISCC PLUS certification for its polyurethane production at the Düsseldorf site, marking the third European Henkel facility to receive this sustainability ...